Cargando…
抗CD22序贯抗CD19嵌合抗原受体T细胞治疗复发/难治性儿童急性B淋巴细胞白血病2例
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072072/ https://www.ncbi.nlm.nih.gov/pubmed/35405786 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.03.013 |
| _version_ | 1784700975534047232 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9072072 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90720722022-05-06 抗CD22序贯抗CD19嵌合抗原受体T细胞治疗复发/难治性儿童急性B淋巴细胞白血病2例 Zhonghua Xue Ye Xue Za Zhi 病例报告 Editorial office of Chinese Journal of Hematology 2022-03 /pmc/articles/PMC9072072/ /pubmed/35405786 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.03.013 Text en 2022年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
| spellingShingle | 病例报告 抗CD22序贯抗CD19嵌合抗原受体T细胞治疗复发/难治性儿童急性B淋巴细胞白血病2例 |
| title | 抗CD22序贯抗CD19嵌合抗原受体T细胞治疗复发/难治性儿童急性B淋巴细胞白血病2例 |
| title_full | 抗CD22序贯抗CD19嵌合抗原受体T细胞治疗复发/难治性儿童急性B淋巴细胞白血病2例 |
| title_fullStr | 抗CD22序贯抗CD19嵌合抗原受体T细胞治疗复发/难治性儿童急性B淋巴细胞白血病2例 |
| title_full_unstemmed | 抗CD22序贯抗CD19嵌合抗原受体T细胞治疗复发/难治性儿童急性B淋巴细胞白血病2例 |
| title_short | 抗CD22序贯抗CD19嵌合抗原受体T细胞治疗复发/难治性儿童急性B淋巴细胞白血病2例 |
| title_sort | 抗cd22序贯抗cd19嵌合抗原受体t细胞治疗复发/难治性儿童急性b淋巴细胞白血病2例 |
| topic | 病例报告 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072072/ https://www.ncbi.nlm.nih.gov/pubmed/35405786 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.03.013 |
| work_keys_str_mv | AT kàngcd22xùguànkàngcd19qiànhékàngyuánshòutǐtxìbāozhìliáofùfānánzhìxìngértóngjíxìngblínbāxìbāobáixuèbìng2lì AT kàngcd22xùguànkàngcd19qiànhékàngyuánshòutǐtxìbāozhìliáofùfānánzhìxìngértóngjíxìngblínbāxìbāobáixuèbìng2lì AT kàngcd22xùguànkàngcd19qiànhékàngyuánshòutǐtxìbāozhìliáofùfānánzhìxìngértóngjíxìngblínbāxìbāobáixuèbìng2lì AT kàngcd22xùguànkàngcd19qiànhékàngyuánshòutǐtxìbāozhìliáofùfānánzhìxìngértóngjíxìngblínbāxìbāobáixuèbìng2lì AT kàngcd22xùguànkàngcd19qiànhékàngyuánshòutǐtxìbāozhìliáofùfānánzhìxìngértóngjíxìngblínbāxìbāobáixuèbìng2lì AT kàngcd22xùguànkàngcd19qiànhékàngyuánshòutǐtxìbāozhìliáofùfānánzhìxìngértóngjíxìngblínbāxìbāobáixuèbìng2lì AT kàngcd22xùguànkàngcd19qiànhékàngyuánshòutǐtxìbāozhìliáofùfānánzhìxìngértóngjíxìngblínbāxìbāobáixuèbìng2lì AT kàngcd22xùguànkàngcd19qiànhékàngyuánshòutǐtxìbāozhìliáofùfānánzhìxìngértóngjíxìngblínbāxìbāobáixuèbìng2lì |